Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

malignant melanoma

  • You have access
    Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
    CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND
    Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793
  • You have access
    Nivolumab for the Treatment of Advanced Pediatric Malignancies
    AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI and JAN STYCZYŃSKI
    Anticancer Research December 2020, 40 (12) 7095-7100; DOI: https://doi.org/10.21873/anticanres.14738
  • You have access
    Melanoma Risk Estimation Based on Objective Measures as a Complement to Self-Assessment
    ADAM CARLSSON and MAGNUS FALK
    Anticancer Research June 2020, 40 (6) 3325-3331; DOI: https://doi.org/10.21873/anticanres.14315
  • You have access
    National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma
    MARIA T. HUAYLLANI, DAVID J. RESTREPO, DANIEL BOCZAR, FRANCISCO R. AVILA, SANJAY P. BAGARIA, AARON C. SPAULDING, BRIAN D. RINKER and ANTONIO J. FORTE
    Anticancer Research June 2020, 40 (6) 3411-3415; DOI: https://doi.org/10.21873/anticanres.14325
  • You have access
    Association of Vitamin D Receptor Gene Polymorphisms With Melanoma Risk: A Meta-analysis and Systematic Review
    MICHELLE BIRKE, JAKOB SCHÖPE, STEFAN WAGENPFEIL, THOMAS VOGT and JÖRG REICHRATH
    Anticancer Research February 2020, 40 (2) 583-595; DOI: https://doi.org/10.21873/anticanres.13988
  • You have access
    Efficacy and Toxicity of Pembrolizumab in Pediatric Metastatic Recurrent Melanoma
    AGATA MARJANSKA, PRZEMYSLAW GALAZKA, MICHAL MARJANSKI, MARIUSZ WYSOCKI and JAN STYCZYNSKI
    Anticancer Research July 2019, 39 (7) 3945-3947; DOI: https://doi.org/10.21873/anticanres.13547
  • You have access
    Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma
    THEODORA MANTSO, STAVROS VASILEIADIS, EVANGELI LAMPRI, SOTIRIS BOTAITIS, SEBACHEDIN PERENTE, CONSTANTINOS SIMOPOULOS, KATERINA CHLICHLIA, AGLAIA PAPPA and MIHALIS I. PANAYIOTIDIS
    Anticancer Research May 2019, 39 (5) 2307-2315; DOI: https://doi.org/10.21873/anticanres.13347
  • You have access
    Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
    DIRK RADES, LENA SEHMISCH, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN and STEVEN E. SCHILD
    Anticancer Research March 2019, 39 (3) 1501-1505; DOI: https://doi.org/10.21873/anticanres.13268
  • You have access
    Isothiocyanate-induced Cell Cycle Arrest in a Novel In Vitro Exposure Protocol of Human Malignant Melanoma (A375) Cells
    THEODORA MANTSO, IOANNIS ANESTOPOULOS, ELEFTHERIA LAMPRIANIDOU, IOANNIS KOTSIANIDIS, AGLAIA PAPPA and MIHALIS I. PANAYIOTIDIS
    Anticancer Research February 2019, 39 (2) 591-596; DOI: https://doi.org/10.21873/anticanres.13152
  • You have access
    Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of PFKFB4 Overexpression for Disease Progression
    SONIA E. TROJAN, MONIKA PIWOWAR, BARBARA OSTROWSKA, PIOTR LAIDLER and KINGA A. KOCEMBA-PILARCZYK
    Anticancer Research December 2018, 38 (12) 6745-6752; DOI: https://doi.org/10.21873/anticanres.13044

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire